Contribute Try STAT+ Today

The gradual global shift towards sustainability, with an increased focus on climate change and environmental impact, is an essential movement. I’m concerned that few companies in the pharmaceutical industry have made substantial efforts to join the drive to achieve social, economic, and environmental progress and prosperity.

The development and production of drugs requires a significant amount of natural, human, and economic resources, representing myriad risks to the environment and the sustainability of the industry. But there are ways to mitigate these risks and turn that work into opportunities.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.